#news #biotech In a first, Janssen submits lung cancer bispecific hopeful amivantamab to the FDA

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: In a first, Janssen submits lung cancer bispecific hopeful amivantamab to the FDA .In a first, Janssen submits lung cancer bispecific hopeful amivantamab to the FDA
badams
Thu, 12/03/2020 – 09:20

from FierceBiotech: Biotech https://ift.tt/3g6quMN